AU2001257893A1 - Multiple inactivated blood factor anticoagulant composition - Google Patents

Multiple inactivated blood factor anticoagulant composition

Info

Publication number
AU2001257893A1
AU2001257893A1 AU2001257893A AU5789301A AU2001257893A1 AU 2001257893 A1 AU2001257893 A1 AU 2001257893A1 AU 2001257893 A AU2001257893 A AU 2001257893A AU 5789301 A AU5789301 A AU 5789301A AU 2001257893 A1 AU2001257893 A1 AU 2001257893A1
Authority
AU
Australia
Prior art keywords
blood factor
anticoagulant composition
inactivated blood
multiple inactivated
factor anticoagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257893A
Inventor
Richard J. Johnson
Roger Lundblad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of AU2001257893A1 publication Critical patent/AU2001257893A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
AU2001257893A 2000-01-13 2000-12-20 Multiple inactivated blood factor anticoagulant composition Abandoned AU2001257893A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17582100P 2000-01-13 2000-01-13
US60/175821 2000-01-13
US74023900A 2000-12-18 2000-12-18
US09/740239 2000-12-18
PCT/US2000/034734 WO2001051067A1 (en) 2000-01-13 2000-12-20 Multiple inactivated blood factor anticoagulant composition

Publications (1)

Publication Number Publication Date
AU2001257893A1 true AU2001257893A1 (en) 2001-07-24

Family

ID=26871605

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001257893A Abandoned AU2001257893A1 (en) 2000-01-13 2000-12-20 Multiple inactivated blood factor anticoagulant composition

Country Status (2)

Country Link
AU (1) AU2001257893A1 (en)
WO (1) WO2001051067A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102568D0 (en) * 2001-02-01 2001-03-21 Magnetic Biosolutions Sweden A Method
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
GB0710321D0 (en) * 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
CN112941143A (en) * 2021-01-28 2021-06-11 南京可诺医疗技术有限公司 Simple and convenient reagent for detecting blood coagulation and platelet functions and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120537A (en) * 1989-06-14 1992-06-09 Oklahoma Medical Research Foundation Factor xa based anticoagulant compositions
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors

Also Published As

Publication number Publication date
WO2001051067A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AU2002227441A1 (en) Biocompatible adhesives
AU2001241963A1 (en) Improved medical procedure
AU2001281758A1 (en) Biocompatible materials
AU2002212006A1 (en) Artificial disc
AU9517301A (en) Implant
AU2001249990A1 (en) Balance prosthesis
AU2001260327A1 (en) Chair
AU2002248304A1 (en) Vascular tissue composition
AU2002356967A1 (en) Catheter
AU2001274548A1 (en) Syringe
AU2001280598A1 (en) Anti-occlusion catheter
AU2001259702A1 (en) Tissue regrafting
AU2002355230A1 (en) Blood dialyzer
AU4439701A (en) Patient support
AU2002221131A1 (en) Blood lipid ameliorant composition
AU2002227925A1 (en) Human beta-defensin-3
AU2001257893A1 (en) Multiple inactivated blood factor anticoagulant composition
AU2001247841A1 (en) Medical procedure
AU2001252200A1 (en) Chair
AU2001295815A1 (en) Multiple purpose catheter
AU2002215481A1 (en) Improved medical sampler
AUPR069500A0 (en) Tissue modification
AU2002221130A1 (en) Blood lipid ameliorant composition
AU2001284827A1 (en) Virtual showcases
AU2000279374A1 (en) Secure syringe